Atlas Trials

OncoVerity, Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch OncoVerity, Inc.

RecordFirmDate
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy (NCT06384261)OncoVerity, Inc.2024-07-22
A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment (NCT04241549)OncoVerity, Inc.2020-03-25
Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia (NCT04150887)OncoVerity, Inc.2019-12-23
A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy (NCT04023526)OncoVerity, Inc.2019-07-29

Track OncoVerity, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.